Trevena Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TREVENA, and when can generic versions of TREVENA drugs launch?
TREVENA has one approved drug.
There are four US patents protecting TREVENA drugs.
There are forty-three patent family members on TREVENA drugs in twenty-three countries.
Drugs and US Patents for Trevena
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | RX | Yes | Yes | 9,309,234 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-003 | Oct 30, 2020 | RX | Yes | Yes | 11,077,098 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | 8,835,488 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | RX | Yes | Yes | 11,077,098 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Trevena Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2018048193 | ⤷ Try a Trial |
Cyprus | 1119057 | ⤷ Try a Trial |
Slovenia | 2688403 | ⤷ Try a Trial |
New Zealand | 713143 | ⤷ Try a Trial |
Israel | 284407 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.